ClinicalTrials.Veeva

Menu
C

Chernivtsi Regional Clinical Hospital | Pulmonology Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Methotrexate
Ozanimod
Erdafitinib
Pembrolizumab
GLPG0634
Vinflunine
Mirikizumab
GLPG0259
Docetaxel
Relamorelin

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 11 total trials

A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease (VIVID-2)

The reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn's disease.

Enrolling
Crohn's Disease
Drug: Mirikizumab

This is a study to demonstrate the effect of oral ozanimod as maintenance therapy in participants with moderately to severely active Crohn's Disease.

Active, not recruiting
Crohn Disease
Other: Placebo
Drug: Ozanimod

The purpose of this study is to evaluate efficacy of erdafitinib versus chemotherapy or pembrolizumab in participants with advanced urothelial cancer...

Active, not recruiting
Urothelial Cancer
Drug: Erdafitinib
Drug: Docetaxel

This is an extension study to evaluate safety and efficacy of ozanimod in participants with moderately to severely active Crohn's Disease.

Enrolling
Crohn Disease
Drug: Ozanimod

A Phase 2 study to evaluate the safety, efficacy, and microbiota changes of VE202 in patients with mild to moderate ulcerative colitis (UC).

Enrolling
Colitis, Ulcerative
Ulcerative Colitis
Other: Vancomycin Placebo
Drug: Vancomycin Oral Capsule

Trial sponsors

Celgene logo
G
Allergan logo
G
Janssen (J&J Innovative Medicine) logo
Lilly logo
Pfizer logo
S
V

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems